| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,138,913 ) |
| | 2025 | 2025 | NOB HILL THERAPEUTICS, INC. | 5901 INDIAN SCHOOL RD NE | ALBUQUERQUE | NM | 87110-5200 | BERNALILLO | USA | R44CA281538 | Aerosolized Epigenetic Therapy for Metastatic Lung Cancer | 000 | 2 | NIH | 12/20/2024 | $1,138,913 |
| | 2025 | 2023 | NOB HILL THERAPEUTICS, INC. | 5901 INDIAN SCHOOL RD NE | ALBUQUERQUE | NM | 87110-5200 | BERNALILLO | USA | R44HL147749 | Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | 000 | 3 | NIH | 12/9/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | NOB HILL THERAPEUTICS, INC. | 5901 INDIAN SCHOOL RD NE | ALBUQUERQUE | NM | 87110-5200 | BERNALILLO | USA | R44CA281538 | Aerosolized Epigenetic Therapy for Metastatic Lung Cancer | 000 | 1 | NIH | 8/29/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,425,390 ) |
| | 2023 | 2023 | NOB HILL THERAPEUTICS INC | 5901 INDIAN SCHOOL RD NE | ALBUQUERQUE | NM | 87110-5200 | BERNALILLO | USA | R44CA281538 | Aerosolized Epigenetic Therapy for Metastatic Lung Cancer | 000 | 1 | NIH | 9/19/2023 | $861,087 |
| | 2023 | 2023 | NOB HILL THERAPEUTICS INC | 5901 INDIAN SCHOOL RD NE | ALBUQUERQUE | NM | 87110-5200 | BERNALILLO | USA | R44HL147749 | Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | 000 | 3 | NIH | 6/19/2023 | $564,303 |
|
| Issue Date FY: 2022 ( Subtotal = $1,158,273 ) |
| | 2022 | 2022 | NOB HILL THERAPEUTICS, INC. | 5901 INDIAN SCHOOL RD NE UNIT 209 | ALBUQUERQUE | NM | 87110-5200 | BERNALILLO | USA | R44HL147749 | Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | 000 | 2 | NIH | 6/28/2022 | $1,158,273 |
| | 2022 | 2020 | NOB HILL THERAPEUTICS INC | 5901 INDIAN SCHOOL RD NE | ALBUQUERQUE | NM | 87110-5200 | BERNALILLO | USA | R43HL147749 | Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | 000 | 1 | NIH | 1/31/2022 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $299,058 ) |
| | 2020 | 2020 | NOB HILL THERAPEUTICS, INC. | 5901 INDIAN SCHOOL RD NE UNIT 209 | ALBUQUERQUE | NM | 87110-5200 | BERNALILLO | USA | R43HL147749 | Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections | 000 | 1 | NIH | 2/6/2020 | $299,058 |
|
|
